Replies to post #39192 on Imaging Diagnostic Systems (fka IMDS)

[ronrooster]

Incorrect, these guys are filing, please see following;



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 10-Q



[Mark One]

? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the quarterly period ended December 31, 2021



or



? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the transition period from _____to______



Commission file number: 000-26028







IMAGING DIAGNOSTIC SYSTEMS, INC.

(Exact name of registrant as specified in its charter)



Florida 22-2671269
(State of
Incorporation) (IRS Employer
Ident. No.)

618 E South St, Suite 500, Orlando, FL 32801
(Address of Principal Executive Offices) (Zip Code)


Registrant’s telephone number: [phone]



Securities registered pursuant to Section 12(b) of the Act:



Title of each class Trading Symbol(s) Name of each exchange on which registered



Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ? No ?



Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ? No ?



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer ? Accelerated filer ? Smaller reporting company ?
Non-accelerated filer ? Emerging growth company ?


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?



Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes ? No ?



The number of shares outstanding of the issuer’s common stock as of February 15, 2022: 123,156,941 shares of common stock, no par value.